In multiple sclerosis (MS), a chronic inflammatory and neurodegenerative disease of the central nervous system, the body attacks the protective myelin sheath of neurons in the brain and the spinal cord. The damaged myelin causes communication problems between the central nervous system and the rest of the body. To this day, there is no cure for MS.
Multiple sclerosis is the most common autoimmune disorder of the central nervous system. Globally, about 3 million people living with the disease, an estimated 300 people get diagnosed every day.
Neurobiological researchers believe that multiple sclerosis does not only cause the clinical symptoms we look for today but also alters a patient’s lipid metabolism. Detailed, molecular lipid analysis can discover specific biomarkers for MS to support fast and accurate diagnosis, better treatment, and monitoring.
Read about lipid biomarkers of multiple sclerosis here:
#lipid #lipidomics #MultipleSclerosis #LipidMetabolism
